Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Jaeger

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
BMC Gastroenterology|December 6, 2015
Outcomes and risk factors for cancer patients undergoing endoscopic intervention of malignant biliary obstructionGeorg-Martin Haag, Thomas Herrmann, Dirk Jaeger, et al.
Annals of Surgery|April 7, 2007
Surgery for recurrent pancreatic ductal adenocarcinomaJörg Kleeff, Carolin Reiser, Ulf Hinz, et al.
World Journal of Gastrointestinal Oncology|November 30, 2020
Cancer-related microangiopathic hemolytic anemia in patients with advanced gastric cancer: A retrospective single-center analysisAnne Katrin Berger, Michael Allgäuer, Leonidas Apostolidis, et al.
Oncoimmunology|April 14, 2017
Detailed resolution analysis reveals spatial T cell heterogeneity in the invasive margin of colorectal cancer liver metastases associated with improved survivalAnna Berthel, Inka Zoernig, Nektarios A Valous, et al.
Anticancer Research|November 5, 2014
Efficacy of nab-paclitaxel does not seem to be associated with SPARC expression in metastatic breast cancerAndreas Schneeweiss, Julia Seitz, Katharina Smetanay, et al.
Cells|September 28, 2023
The Role and Therapeutic Targeting of CCR5 in Breast CancerRasha Hamid, Mustafa Alaziz, Amanpreet S Mahal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid TumorsTobias Speck, Johannes P W Heidbuechel, Rūta Veinalde, et al.
Plos One|September 6, 2014
Pan-Bcl-2 inhibitor obatoclax delays cell cycle progression and blocks migration of colorectal cancer cellsBruno Christian Koehler, Anna-Lena Scherr, Stephan Lorenz, et al.
International Journal of Cancer|July 23, 2008
Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrenceDaniel Perez, Thomas Herrmann, Achim A Jungbluth, et al.
Human Gene Therapy|May 7, 2013
Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccineChristian Grossardt, Christine E Engeland, Sascha Bossow, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
BMC Gastroenterology|December 6, 2015
Outcomes and risk factors for cancer patients undergoing endoscopic intervention of malignant biliary obstructionGeorg-Martin Haag, Thomas Herrmann, Dirk Jaeger, et al.
Annals of Surgery|April 7, 2007
Surgery for recurrent pancreatic ductal adenocarcinomaJörg Kleeff, Carolin Reiser, Ulf Hinz, et al.
World Journal of Gastrointestinal Oncology|November 30, 2020
Cancer-related microangiopathic hemolytic anemia in patients with advanced gastric cancer: A retrospective single-center analysisAnne Katrin Berger, Michael Allgäuer, Leonidas Apostolidis, et al.
Oncoimmunology|April 14, 2017
Detailed resolution analysis reveals spatial T cell heterogeneity in the invasive margin of colorectal cancer liver metastases associated with improved survivalAnna Berthel, Inka Zoernig, Nektarios A Valous, et al.
Anticancer Research|November 5, 2014
Efficacy of nab-paclitaxel does not seem to be associated with SPARC expression in metastatic breast cancerAndreas Schneeweiss, Julia Seitz, Katharina Smetanay, et al.
Cells|September 28, 2023
The Role and Therapeutic Targeting of CCR5 in Breast CancerRasha Hamid, Mustafa Alaziz, Amanpreet S Mahal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid TumorsTobias Speck, Johannes P W Heidbuechel, Rūta Veinalde, et al.
Plos One|September 6, 2014
Pan-Bcl-2 inhibitor obatoclax delays cell cycle progression and blocks migration of colorectal cancer cellsBruno Christian Koehler, Anna-Lena Scherr, Stephan Lorenz, et al.
International Journal of Cancer|July 23, 2008
Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrenceDaniel Perez, Thomas Herrmann, Achim A Jungbluth, et al.
Human Gene Therapy|May 7, 2013
Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccineChristian Grossardt, Christine E Engeland, Sascha Bossow, et al.
Pageof 6